Abstract
Methods to infuse drugs into the parenchyma of the central nervous system (CNS) have been reported as inconsistent or unpredictable. The source of variability appears to be a compromised seal between the tissue and the outer surface of the cannula. Failure of the tissue to seal to the cannula creates a path of least resistance. Rather than penetrate the target area, the drug backflows along the path of the cannula. This artifact can be difficult to detect because drugs enter the systemic circulation and provide some fraction of the intended therapy.
Decreasing the rate of the infusion can reduce backflow. However, this may not be an attractive option for certain therapeutic targets because decreased infusion rates decrease the volume of drug distribution in normal tissue. Cannula design plays a role. Rigid catheters that are fixed to the skull will oppose movements of the brain and break the seal between the catheter and the tissue during chronic infusions. Flexible infusion cannulas, which can be readily made by modifying commercially available brain infusion catheters with plastic tubing, appear to provide consistent infusion results because they can move with the brain and maintain their tissue seal.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
1. Routtenberg A (1972) Intracranial chemical injection and behavior: a critical review. Behav Biol 7:601-641.
2. Ott T, Schmitt M, Krug M, Matthies H (1974) Intrahippocampal injection of chemicals: analysis of spread. Pharmacol Biochem Behav 2:715-718.
3. Crane LA, Glick SD (1979) Simple cannula for repeated intracerebral drug administration in rats. Pharmacol Biochem Behav 10:799-800.
4. Rezek M, Havlicek V (1975) Cannula for intracerebral administration of experimental substances. Pharmacol Biochem Behav 3:1125-1128.
5. Kokkinidis L, Raffler L, Anisman H (1977) Simple and compact cannula system for mice. Pharmacol Biochem Behav 6:595-597.
6. Williams LR, Vahlsing HL, Lindamood T, Varon S, Gage FH, Manthorpe M (1987) A small-gauge cannula device for continuous infusion of exogenous agents into the brain. Exp Neurol 95:743-754.
7. Lal S, Lacroix M, Tofilon P, Fuller GN, Sawaya R, Lang FF (2000) An implantable guide-screw system for brain tumor studies in small animals. J Neurosurg 92:326-333.
8. Theeuwes F, Yum SI (1976) Principles of the design and operation of generic osmotic pumps for the delivery of semisolid or liquid drug formulations. Ann Biomed Eng 4:343-353.
9. White JD, Schwartz MW (1994) Using osmotic minipumps for intracranial delivery of amino acids and peptides. In: Flanagan TR, Emerich DF, Winn SR (eds) Methods in neurosciences, vol 21. Academic, San Diego, CA, 187-200.
10. Wright JC, Stevenson CL (1999) Pumps/osmotic. In: Mathiowitz E (ed) Encyclopedia of controlled drug delivery. Wiley, New York, 896-915.
11. Kroin JS, Penn RD (1982) Intracerebral chemotherapy: chronic microinfusion of cisplatin. Neurosurgery 10:349-354.
12. Penn RD, Kroin JS, Harris JE, Chiu KM, Braun DP (1983) Chronic intratumoral chemotherapy of a rat tumor with cisplatin and fluorouracil. Appl Neurophysiol 46:240-244.
13. Kimler BF, Martin DF, Evans RG, Morantz RA, Vats TS (1990) Combination of radiation therapy and intracranial bleomycin in the 9L rat brain tumor model. Int J Radiat Oncol Biol Phys 18:1115-1121.
14. Ram Z, Samid D, Walbridge S, Oshiro E, Viola J, Tao-cheng J-H, Shack S, Thibault A, Meyers C, Oldfield E (1994) Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenyl acetate. Cancer Res 54:2923-2927.
15. Pollina J, Plunkett RJ, Ciesielski MJ, Lis A, Barone TA, Greenberg SJ, Fenstermaker RA (1998) Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model. J Neurooncol 39:217-225.
16. Viola JJ, Agbaria A, Walbridge S, Oshiro EM, Johns DG, Kelly JA, Oldfield EH, Ram Z (1995) In situ cyclopentenyl cytosine infusion for the treatment of experimental brain tumors. Cancer Res 55:1306-1309.
17. Carson BS, Wu QZ, Tyler B, Sukay L, Raychaudhuri R, DiMeco F, Clatterbuck R, Olivi A, Guarnieri M (2002) New approach to tumor therapy for inoperable areas of the brain: chronic intraparenchymal drug delivery. J Neurooncol 60:151-158.
18. Storm PB, Clatterbuck RE, Liu YJ, Johnson RM, Gillis EM, Guarnieri M, Carson BS (2003) A surgical technique for safely placing a drug delivery catheter into the pons of primates: preliminary results of carboplatin infusion. Neurosurgery 52:1169-1177.
19. Carson Sr BS, Guarnieri M (2002) Local therapy for brain tumors. Adv Clin Neurosci 12:89-99.
20. Groothuis DR (2000) The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery. Neurooncol 2:45-59.
21. Weingart J, Rhines L, Brem H (2000) Intratumoral chemotherapy. In: Bernstein M, Berger MS (eds) Neuro-oncology. The essentials. Thieme, New York, 240-248.
22. Wang PP, Frazier J, Brem H (2002) Local drug delivery to the brain. Adv Drug Deliv Rev 54:987-1013.
23. Khan A, Jallo GI, Liu YJ, Carson Sr BS, Guarnieri M (2005) Infusion rates and drug distribution in brain tumor models. J Neurosurg (Pediatr 1) 102:53-58.
24. Fung LK, Ewend MG, Aills A, Sipos EP, Thompson R, Watts M, Colvin OM, Brem H, Saltzman WM (1998) Pharmacokinetics of interstitial delivery of carmustine, 4-hydroperoxycyclophosphamide, and paclitaxel from a biodegradable polymer implant in the monkey brain. Cancer Res 58:672-684.
25. Morikawa N, Mori T, Abe T, Kawashima H, Takeyama M, Hori S (1999) Pharmacokinetics of etoposide and carboplatin in cerebrospinal fluid and plasma during hyperosmotic disruption of the blood brain barrier and intraarterial combination chemotherapy. Biol Pharm Bull 22:428-431.
26. Reulen HJ, Grahm R, Spatz M, Klatzo I (1977) Role of pressure gradients and bulk flow in dynamics of vasogenic brain edema. J Neurosurg 46:24-34.
27. Krauze MT, Saito R, Noble C, Tamas M, Bringas J, Park JW, Berger MS, Bankiewicz K (2005) Reflux-free cannnula for convection-enhanced high-speed delivery of therapeutic agents. J Neurosurg 103:923-929.
28. Salcman M, Scott EW, Schepp RS, Knipp HC, Broadwell RD (1982) Transplantable canine glioma model for use in experimental neuro-oncology. Neurosurgery 11:372-381.
29. Szabo J, Cowan WM (1984) A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J Comp Neurol 222:265-300.
30. Barabas K, Sizensky J, Faulk WP (1992) Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA. J Biol Chem 267:9437-9442.
31. Bear MF, Kleinschmidt A, Gu Q, Singer W (1990) Disruption of experience-dependent synaptic modification in striate cortex by infusion of an NMDA receptor antagonist. J Neurosci 10:909-925.
32. Cunningham J, Oiwa Y, Nagy D, Podsakoff G, Colosi P, Bankiewicz KS (2000) Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant 9:585-594.
33. Wu Q, Tyler B, Sukay L, Rhines L, DiMeco F, Clatterbuck RE, Guarnieri M, Carson Sr BS. (2002) Experimental rodent models of brainstem tumors. Vet Pathol 39:293-299.
Acknowledgments
The authors have received financial support from DURECT Inc. (Cupertino, CA) to examine the toxicity of carboplatin infused into the brainstem of monkeys via an osmotic pump. Financial aid for the present study has been supplied entirely by the Children's Cancer Foundation (Baltimore, MD).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Humana Press, a part of Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Guarnieri, M., Carson, B.S., Jallo, G.I. (2008). Catheters for Chronic Administration of Drugs into Brain Tissue. In: Jain, K.K. (eds) Drug Delivery Systems. Methods in Molecular Biology™, vol 437. Humana Press. https://doi.org/10.1007/978-1-59745-210-6_4
Download citation
DOI: https://doi.org/10.1007/978-1-59745-210-6_4
Publisher Name: Humana Press
Print ISBN: 978-1-58829-891-1
Online ISBN: 978-1-59745-210-6
eBook Packages: Springer Protocols